ANIX - CIK 0000715446
Anixa Biosciences Inc has filed 960 documents with the SEC between 1995 and 2026. The most frequent type is insider trade (415 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2026-03-11 | 2026-03-10 |
| Quarterly report | 10-Q | 2026-03-09 | 2026-01-31 |
| Major company event | 8-K | 2026-02-09 | 2026-02-09 |
| Insider trade | 4 | 2026-01-29 | 2026-01-28 |
| Proxy statement | DEF 14A | 2026-01-28 | 2026-01-28 |
| Employee stock plan | S-8 | 2026-01-12 | - |
| Annual report | 10-K | 2026-01-12 | 2025-10-31 |
| SCHEDULE 13D/A | - | 2026-01-06 | - |
| Insider trade | 4 | 2026-01-06 | 2026-01-05 |
| Insider trade | 4 | 2026-01-06 | 2026-01-05 |
| Insider trade | 4 | 2026-01-06 | 2026-01-05 |
| Insider trade | 4 | 2026-01-06 | 2026-01-05 |
| Insider trade | 4 | 2026-01-06 | 2026-01-05 |
| Insider trade | 4 | 2025-12-16 | 2025-12-15 |
| Major company event | 8-K | 2025-12-12 | 2025-12-11 |
| Insider trade | 4 | 2025-10-31 | 2025-10-30 |
| EFFECT | - | 2025-09-30 | - |
| Company correspondence | CORRESP | 2025-09-26 | - |
| SEC correspondence | UPLOAD | 2025-09-16 | - |
| Securities registration | S-3 | 2025-09-10 | - |
| Quarterly report | 10-Q | 2025-09-10 | 2025-07-31 |
| Insider trade | 4 | 2025-08-04 | 2025-07-31 |
| Insider trade | 4 | 2025-07-31 | 2025-07-30 |
| Insider trade | 4 | 2025-07-21 | 2025-07-18 |
| Insider trade | 4 | 2025-07-15 | 2025-07-11 |
| Insider trade | 4 | 2025-07-14 | 2025-07-11 |
| SCHEDULE 13D/A | - | 2025-06-06 | - |
| Insider trade | 4 | 2025-06-05 | 2025-06-04 |
| Quarterly report | 10-Q | 2025-05-28 | 2025-04-30 |
| Major company event | 8-K | 2025-03-21 | 2025-03-20 |
| Quarterly report | 10-Q | 2025-03-11 | 2025-01-31 |
| Proxy statement | DEF 14A | 2025-02-06 | 2024-10-31 |
| Insider trade | 4 | 2025-01-29 | 2025-01-28 |
| Insider trade | 4 | 2025-01-27 | 2025-01-23 |
| Insider trade | 4 | 2025-01-23 | 2025-01-22 |
| Insider trade | 4 | 2025-01-22 | 2025-01-21 |
| Insider trade | 4 | 2025-01-17 | 2025-01-17 |
| Insider trade | 4 | 2025-01-15 | 2025-01-15 |
| Insider trade | 4 | 2025-01-15 | 2025-01-15 |
| Employee stock plan | S-8 | 2025-01-10 | - |
| Annual report | 10-K | 2025-01-10 | 2024-10-31 |
| SCHEDULE 13D/A | - | 2025-01-03 | - |
| Insider trade | 4 | 2025-01-03 | 2025-01-02 |
| Insider trade | 4 | 2025-01-03 | 2025-01-02 |
| Insider trade | 4 | 2025-01-03 | 2025-01-02 |
| Insider trade | 4 | 2025-01-03 | 2025-01-02 |
| Insider trade | 4 | 2025-01-03 | 2025-01-02 |
| Major company event | 8-K | 2024-11-08 | 2024-11-08 |
| Insider trade | 4 | 2024-10-23 | 2024-10-22 |
| Quarterly report | 10-Q | 2024-09-06 | 2024-07-31 |